Drug Topics
NOVEMBER 7, 2023
A Q&A with Ginny Langbehn, vice president of marketing and communications at American Associated Pharmacies, about different strategies pharmacies can use to bring in new customers.
Pharmacy Times
NOVEMBER 8, 2023
Atta Chowdhry, RPh, and Robert Sidonio Jr, MD, MSc, discuss the emergence of gene therapy as an exciting option for patients with hemophilia A and highlight benefits, limitations, and ongoing research in the field.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
NOVEMBER 10, 2023
Pharmacies were once abundant in the South Side of Chicago. Now, residents living in the majority Black neighborhood often find themselves with few options when it’s time to get a prescription refilled or stock up on cold medicine. Ladell Johnson, a longtime resident of the South Side, drives half an hour from her house to the downtown area every time she needs to pick up her prescription.
Fierce Healthcare
NOVEMBER 5, 2023
Family physicians utilizing value-based payment (VBP) models reported burnout relief in a new study from EHR com | The study found that higher capitation rates combined with greater overall percentage of revenue from capitation resulted in the biggest reduction in physician burnout.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
NOVEMBER 6, 2023
Although long COVID has emerged as a major public health concern, it has not yet been clearly identified as a clinical condition.
Pharmacy Times
NOVEMBER 8, 2023
Tirzepatide is already approved under the brand name Mounjaro (Lilly) to be used along with diet and exercise to improve blood sugar in adults with type 2 diabetes.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Healthcare
NOVEMBER 8, 2023
Legislative spotlight was put back on pharmacy benefit manager reform and mental health in a comprehensive draft packaged presented by the Senate Finance Committee, which was passed Wednesday 26-0. | A comprehensive healthcare package garnered near unanimous approval on Wednesday, which could lead to big changes for PBMs down the road.
Drug Topics
NOVEMBER 10, 2023
Ixchiq contains a live, weakened version of the chikungunya virus and may cause symptoms in the vaccine recipient similar to those experienced by people who have chikungunya disease.
Pharmacy Times
NOVEMBER 6, 2023
AI is expected to significantly quicken the pace of drug design and development, while improving the success rate of new medicines.
STAT
NOVEMBER 10, 2023
An expert panel that advises the United Kingdom on vaccine policy has recommended using a meningitis B vaccine to try to bring down spiking rates of gonorrhea. If adopted, the U.K. would be the first country to use the meningitis B vaccine for this purpose. The Joint Committee on Vaccination and Immunization released a report Friday saying that targeted use of a meningitis B vaccine — GSK’s Bexsero — in people at high risk of contracting gonorrhea should reduce the inci
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
NOVEMBER 6, 2023
Medicare Advantage (MA) beneficiaries have better quality of care and health outcomes than traditional fee-for-service counterparts, researchers from Harvard Medical School found. | Another white paper released by Inovalon and Harvard Medical School highlights the benefits Medicare Advantage enrollees enjoy over traditional Medicare counterparts.
Drug Topics
NOVEMBER 6, 2023
Unlike traditional THC, which is federally banned, D8 has managed to find a legal loophole, making it widely accessible.
Pharmacy Times
NOVEMBER 7, 2023
AI may help to significantly speed up drug discovery and development, and help researchers end the treatment-resistant infection crisis before it’s too late.
STAT
NOVEMBER 8, 2023
Vaccines work well to prevent cancers caused by the human papillomavirus (HPV). So well, in fact, that it may be time to review HPV screening protocols, according to the somewhat provocative conclusion of a new study examining the occurrence of genital HPV types eight years after immunization, published today in Cell Host & Microbe. The randomized control study included more than 60,000 women from 33 Finnish communities born in 1992, 1993, and 1994.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Pharma
NOVEMBER 7, 2023
Pharma, you were warned. | Only two months after the Federal Trade Commission said it was eying a crackdown on improper patents listed by the FDA, the agency has filed challenges against more than 100 patents in the agency's Orange Book. The companies have 30 days to respond.
Drug Topics
NOVEMBER 8, 2023
The drug, Zepbound, will be available in the United States by the end of 2023.
Pharmacy Times
NOVEMBER 4, 2023
Leung discusses that various cancer types and drugs can cause thrombotic microangiopathy and impact kidney health and the renal complications connected to hematologic malignancies.
STAT
NOVEMBER 9, 2023
In my decade living in Silicon Valley as a digital health journalist and now an investor, I can’t tell you how many times I’ve heard people in the tech industry claim that doctors don’t have what it takes for a career in entrepreneurship. As the traditional thinking goes, because they’re so risk-averse and lack business training, physicians are not well suited to a high-growth, venture-backed startup environment.
Fierce Pharma
NOVEMBER 8, 2023
In the Big Pharma battle to treat obesity, Novo Nordisk sprinted to an early lead, but Eli Lilly is catching up quickly. | In the Big Pharma battle to treat obesity, Novo Nordisk sprinted to an early lead, but Eli Lilly is catching up quickly. Wednesday's FDA approval of Lilly's Zepbound to treat obesity closes the gap further. In addition, Lilly said it will charge 20% less than Novo for its obesity med in an attempt to provide increased access.
Fierce Healthcare
NOVEMBER 7, 2023
Hims & Hers' strong revenue growth streak continued in the third quarter as the digital health and wellness business brought in $227 million, up 57% from a year ago. | With continued strong revenue growth, Hims & Hers expects to be profitable by the first half of 2024. The digital health and wellness company boosted its revenue outlook for the year and announced a new AI-powered service to personalize treatments.
Pharmacy Times
NOVEMBER 4, 2023
Understanding the mechanisms leading to weight loss could help identify potential benefits for cardiorenal health in patients with chronic kidney disease.
STAT
NOVEMBER 8, 2023
Eli Lilly’s blockbuster drug tirzepatide, sold as Mounjaro for type 2 diabetes, has been cleared to treat obesity, making it the second in a highly effective class of weight loss medications to enter the market. The Food and Drug Administration’s long-awaited approval of the drug, which will be marketed under the name Zepbound for obesity, is a major milestone for Lilly.
Fierce Pharma
NOVEMBER 8, 2023
In three years as the pharma chief at Roche, Bill Anderson executed a massive overhaul of the division, lopping off layers of management and recharting its course. | In three years as the pharma chief at Roche, Bill Anderson executed a massive overhaul of the division, lopping off layers of management and recharting its course. Now in his fifth month as CEO at struggling conglomerate Bayer, Anderson is focused on an even larger renovation, saying the company is on its way to a “radical realignme
Fierce Healthcare
NOVEMBER 8, 2023
Mass General Brigham tapped retailer Best Buy Health to scale up its Healthcare at Home services to meet growing demand for home-based care and address workforce shortages. | Mass General Brigham tapped retailer Best Buy Health to scale up its Healthcare at Home services to transition more medical care to patients' homes while also addressing workforce shortages.
Pharmacy Times
NOVEMBER 9, 2023
Women with inflammation during COVID-19 infection are at higher risk for Long Covid symptoms, according to study results.
STAT
NOVEMBER 7, 2023
More than two dozen attorneys general are urging Food and Drug Administration officials to take urgent action to address disparities in how well pulse oximeters, the fingertip devices used to monitor a person’s oxygen levels, work on people with darker skin. In a Nov. 1 letter, the AGs noted that it had been a year since the FDA convened a public meeting of experts , who called for clearer labeling and more rigorous testing of the devices, and that no action had been taken.
Fierce Pharma
NOVEMBER 6, 2023
History may repeat for Vertex Pharmaceuticals in the U.K., where a new decision by the country’s cost-effectiveness gatekeeper threatens to spark another dispute over the cost of lifesaving cystic | Last week, the U.K.'s National Institute for Health and Care Excellence unveiled draft guidance that acknowledged the effectiveness of Vertex’s cystic fibrosis drugs Trikafta, Symkevi and Orkambi.
Fierce Healthcare
NOVEMBER 5, 2023
Healthcare is becoming increasingly unaffordable for many consumers, and rising medical costs often limit patients' access to much-needed care. | The company launched a new software suite, called Affordability Navigator, to connect consumers with outside funding sources and self-service tools. It also integrates Medicaid enrollment into the billing experience.
Pharmacy Times
NOVEMBER 7, 2023
With appointment-based models in community pharmacy, researchers have noted that community pharmacies are well suited for identifying and addressing social determinants of health.
STAT
NOVEMBER 7, 2023
The number of babies born with congenital syphilis in the United States has soared over the last decade, leading to an increase in stillbirths, infant deaths, and life-altering birth defects, the Centers for Disease Control and Prevention reported Tuesday. The number of cases of congenital syphilis in 2022 was more than 10 times the number recorded in 2012, the agency said, noting that most of the 3,761 cases reported in 2022 could have been averted, if the babies’ mothers had been adequa
The Guardian - Pharmaceutical Industry
NOVEMBER 7, 2023
Cure any ailment! Never known to fail! Early medicine adverts made grand claims but they look alarming today The confusion with patent medicines starts with the name, since they were rarely ever patented; manufacturers just thought it sounded cool. Bamboozling was always part of the package: from the 17th century, concoctions of water, alcohol and herbs were sold with wild claims and exotic origin stories.
Fierce Healthcare
NOVEMBER 10, 2023
Nearly two-thirds of specialty centers that conduct autism evaluations have wait times longer than four months, according to a new report. | Nearly two-thirds of specialty centers that conduct autism evaluations have wait times longer than four months, according to a new report.
Pharmacy Times
NOVEMBER 5, 2023
Other than dialysis, Shah notes that patients with kidney disease who are pregnant can receive either nifedipine or labetalol to control blood pressure.
STAT
NOVEMBER 7, 2023
Longtime cancer doctor Monica Bertagnolli is finally heading to the National Institutes of Health director’s office after a nearly two-year effort to install a permanent leader atop the $48 billion science agency. The Senate voted 62-36 Tuesday to confirm her nomination, giving the White House clearance to officially name Bertagnolli the institute’s director, the second woman ever to fill the role.
Expert insights. Personalized for you.
211 
Let's personalize your content